mRNA construct design can be challenging. Read this case study to learn more about how to design multi-epitope mRNA constructs to optimize translation efficiency and target-specific immunogenicity while avoiding junctional epitopes. Read case study
Today, on #internationalwomensday , we’re proud to celebrate the remarkable women of myNEO Therapeutics. Their talent, dedication, and leadership are at the heart of our success. Thank you for your invaluable contributions! #womeninhealthcare
Last week, our team came together for an engaging and informative training session about the cloud-based version of our ImmunoEngine led by Lore Van Oudenhove and Steve Lefever. These training sessions demonstrate our dedication to continuous improvement and knowledge...
myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Additionally, we’re pleased to announce that our CEO, Cedric, received the Medical Genetics award at the Vexillum...
Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer and the particular requirements for unravelling new biomarkers and predicting treatment response warrants a novel...
We are very happy to share our latest review paper! The power of personalized immunotherapy is becoming more and more apparent. The data presented at the AACR Annual meeting and the Neoantigen Summit this spring is exciting and showcases the momentum...
